Investing

Top Analyst Upgrades and Downgrades: Ambarella, Annaly, Cinedigm, Fortinet, Kinder Morgan, 3M, Nikola, Nvidia, Tesla, Uber, YETI and More

Hexcel Corp. (NYSE: HXL) was started with a Buy rating and a $52 price target (versus a $45.12 close) at Seaport Global.

Illumina Inc. (NASDAQ: ILMN) was downgraded to Neutral from Buy at Guggenheim.

Kinder Morgan Inc. (NYSE: KMI) was downgraded to Sell from Neutral and its price target was lowered to $15 from $16 (versus a $15.19 close) at Goldman Sachs. Kinder Morgan had a $17.85 prior consensus target price.

Nikola Corp. (NASDAQ: NKLA) was started with a Sector Perform rating and a $46 price target at RBC Capital Markets. Shares fell by over 14% to $48.92 on Monday and were down over 4% at $46.75 ahead of Tuesday’s opening bell.

Kura Oncology Inc. (NASDAQ: KURA) was started as Outperform with a $27 price target at Credit Suisse. Shares closed at $16.72, with a $24.38 consensus target price, ahead of the call.

3M Co. (NYSE: MMM) was reiterated as Underweight and its price target was cut to $156 from $159 (versus a $158.10 close) at Barclays.

Nautilus Inc. (NYSE: NLS) was reiterated as Buy and its price target was raised to $12 (versus a $10.24 close) at SunTrust Robinson Humphrey.

Nvidia Corp. (NASDAQ: NVDA) was reiterated as Buy and its price objective was raised to $460 from $420 at BofA Securities. Shares closed at $393.57 ahead of this call and had a $388.20 consensus target price. This is above the prior street-high target price of $450.

Sangamo Therapeutics Inc. (NASDAQ: SGMO) was started with a Buy rating and a $22 price target at SunTrust Robinson Humphrey.

Teladoc Health Inc. (NYSE: TDOC) was started with an Overweight rating at Stephens. The stock closed up over 4% at $218 on Monday with a $178.87 consensus target price.

Tesla Inc. (NASDAQ: TSLA) was reiterated as Underweight but its price target was raised to $740 from $650 at Morgan Stanley. Tesla closed up over 13% at $1,371.58 ahead of the call, and its shares are now up over 40% in the past week or so.

Uber Technologies Inc. (NYSE: UBER) was reiterated as Outperform and the price target was raised to $42 from $37 (versus a $32.42 close) at JMP Securities.

Unum Therapeutics Inc. (NASDAQ: UMRX) was raised to Outperform from Neutral with a $4 price target (versus a $2.20 close) at Wedbush.

Vaxcyte Inc. (NASDAQ: PCVX) was started as Buy with a $40 price target (versus a $29.38 close) at Needham. The 52-week range is $17.80 to $36.50.

YETI Holdings Inc. (NYSE: YETI) was downgraded to Neutral from Buy but the price target was raised to $40 from $31 at Goldman Sachs.

In addition, BofA Securities is out with its top picks for the third quarter.